Biotech/Immunotherapy Funding

Sector profile · 1 tracked rounds · $6.7 million tracked capital

Capvizr tracks Biotech/Immunotherapy funding activity across newly funded companies, lead investors, hiring signals, and market narratives.

Top company ARKGEN BioScionsLargest round $7 million1 deals

Recent Biotech/Immunotherapy rounds

ARKGEN BioScions · $6.7 million · Series A · July 14, 2026

Market context

Biotech/Immunotherapy deal flow is monitored for capital concentration, mega-rounds, and hiring expansion.

Open Biotech/Immunotherapy in the interactive Capvizr dashboard →

Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime